Regulus Therapeutics
$8.16
23
+$0.02+0.25% Tuesday 22:00
Statistics
Day High
8.16
Day Low
8.16
52W High
8.35
52W Low
0.83
Volume
8,756,394
Avg. Volume
2,171,516
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
12AugExpected
Expected EPS
-0.25
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-46.36MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow RGLS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Ionis Pharmaceuticals
IONS
Mkt Cap12.03B
Arrowhead Pharmaceuticals
ARWR
Mkt Cap5.86B
Moderna
MRNA
Mkt Cap10.61B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
Sangamo Therapeutics
SGMO
Mkt Cap180.42M
Novartis
NVS
Mkt Cap237.61B
Pfizer
PFE
Mkt Cap140.15B
Roche
RHHBY
Mkt Cap258.9B
About
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Show more...
CEO
Mr. Joseph P. Hagan M.B.A.
Employees
34
Country
US
ISIN
US75915K2006
Listings
0 Comments
Share your thoughts
FAQ
What is Regulus Therapeutics stock price today?▼
The current price of RGLS is $8.16 USD — it has increased by +0.25% in the past 24 hours. Watch Regulus Therapeutics stock price performance more closely on the chart.
What is Regulus Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Regulus Therapeutics stocks are traded under the ticker RGLS.
Is Regulus Therapeutics stock price growing?▼
RGLS stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Regulus Therapeutics has showed a +366.29% increase.
What is Regulus Therapeutics revenue for the last year?▼
Regulus Therapeutics revenue for the last year amounts to 0 USD.
What is Regulus Therapeutics net income for the last year?▼
RGLS net income for the last year is -46.36M USD.
How many employees does Regulus Therapeutics have?▼
As of April 01, 2026, the company has 34 employees.
In which sector is Regulus Therapeutics located?▼
Regulus Therapeutics operates in the Health Care sector.
When did Regulus Therapeutics complete a stock split?▼
The last stock split for Regulus Therapeutics was on June 29, 2022 with a ratio of 1:10.
Where is Regulus Therapeutics headquartered?▼
Regulus Therapeutics is headquartered in San Diego, US.